Cardiovascular medication utilization and adherence among adults living in rural and urban areas: A systematic review and meta-analysis

BMC Public Health

Volumn 14, Issue 1, 2014, Pages

  Murphy, Gaetanne K ^a   McAlister, Finlay A ^a   Weir, Daniala L ^a   Tjosvold, Lisa ^a   Eurich, Dean T ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Cardiovascular diseases; Drug utilization; Medication adherence; Rural population; Urban population

Indexed keywords

CARDIOVASCULAR AGENT;

ADULT; AGED; AUSTRALIA; CANADA; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; EUROPE; FACTUAL DATABASE; FEMALE; HUMAN; META ANALYSIS; MIDDLE AGED; PATIENT COMPLIANCE; RISK FACTOR; RURAL POPULATION; UNITED STATES; URBAN POPULATION; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AUSTRALIA; CANADA; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; DATABASES, FACTUAL; DIABETES MELLITUS, TYPE 2; EUROPE; FEMALE; HUMANS; MIDDLE AGED; PATIENT COMPLIANCE; RISK FACTORS; RURAL POPULATION; UNITED STATES; URBAN POPULATION;

EID: 84903275496     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-14-544     Document Type: Article

References (78)

1. Diabetes burden and access to preventive care in the rural United States. Krishna S, Gillespie KN, McBride TM, J Rural Health 2010 26 3 11 10.1111/j.1748-0361.2009.00259.x 20105262
2. Rural-urban disparities in the management and health issues of chronic diseases in Quebec (Canada) in the early 2000s. Vanasse A, Courteau J, Cohen AA, Orzanco MG, Drouin C, Rural Remote Health 2010 10 1548 21039080
3. Higher risk of death in rural blacks and whites than urbanites is related to lower incomes, education, and health coverage. Probst JC, Bellinger JD, Walsemann KM, Hardin J, Glover SH, Health Aff (Millwood) 2011 30 1872 1879 10.1377/hlthaff.2011.0668 21976329
4. DesMeules M, Pong R, Lagace C, Heng D, Manuel D, Pitblado R, Bollman R, Guernsey J, Kazanjian A, Koren I, How Healthy Are Rural Canadians: An Assessment Of Their Health Status And Health Determinants Ottawa, ON: Canadian Institute for Health Information 2006 https://secure.cihi.ca/free-products/ acknowledgements-rural-canadians-2006-report-e.pdf. Accessed 2012 Sep 01
5. Rural/urban mortality differences in England and Wales and the effect of deprivation adjustment. Gartner A, Farewell D, Roach P, Dunstan F, Soc Sci Med 2011 72 1685 1694 10.1016/j.socscimed.2011.03.017 21524504
6. Addressing the health disadvantage of rural populations: how does epidemiological evidence inform rural health policies and research? Smith KB, Humphreys JS, Wilson MGA, Aust J Rural Health 2008 16 56 66 10.1111/j.1440-1584. 2008.00953.x 18318846 (Pubitemid 351351524)
7. Rural, suburban and urban differences in the self-diagnosis of coronary heart disease in the United States. Jones A, Goza F, J Biosoc Sci 2008 40 895 909 18241524
8. Blood pressure in Spain: distribution, awareness, control, and benefits of a reduction in average pressure. Banegas JR, Rodriguez-Artalejo F, de la Cruz Troca JJ, Guallar-Castillon P, del Rey Calero J, Hypertension 1998 32 998 1002 10.1161/01.HYP.32.6.998 9856963 (Pubitemid 29001426)
9. Prevalence, awareness, treatment and control of hypertension in a general population sample of 26,913 adults in the Greek EPIC study. Psaltopoulou T, Orfanos P, Naska A, Lenas D, Trichopoulos D, Trichopoulou A, Int J Epidemiol 2004 33 1345 1352 10.1093/ije/dyh249 15218014 (Pubitemid 40124939)
10. Patterns of care and outcomes differ for urban versus rural patients with newly diagnosed heart failure, even in a universal healthcare system. Gamble JM, Eurich DT, Ezekowitz JA, Kaul P, Quan H, McAlister FA, Circ Heart Fail 2011 4 317 323 10.1161/CIRCHEARTFAILURE.110.959262 21430285
11. Rural-urban differentials in 30-day and 1-year mortality following first-ever heart failure hospitalisation in Western Australia: a population-based study using data linkage. Teng T-HK, Katzenellenbogen JM, Hung J, Knuiman M, Sanfilippo FM, Geelhoed E, Hobbs M, Thompson SC, BMJ Open 2014 4 004724 10.1136/bmjopen-2013-004724 24793254
12. Urban-rural inequalities in ischemic heart disease in Scotland, 1981-1999. Levin KA, Leyland AH, Am J Public Health 2006 96 145 151 10.2105/AJPH.2004.051193 16317212 (Pubitemid 43042846)
13. Does relative remoteness affect chronic disease outcomes? Geographic variation in chronic disease mortality in Australia, 2002-2006. Chondur R, Li SQ, Guthridge S, Lawton P, Aust N Z J Public Health 2014 38 117 121 10.1111/1753-6405.12126 24812715
14. Perceived barriers to health care access among rural older adults: a qualitative study. Goins RT, Williams KA, Carter MW, Spencer SM, Solovieva T, J Rural Health 2005 21 206 213 10.1111/j.1748-0361.2005.tb00084.x 16092293 (Pubitemid 41557474)
15. Fordyce MA, Chen FM, Doescher MP, Hart LG, 2005 Physician Supply and Distribution in Rural Areas of the United States. Final Report WWAMI Rural Health Research Center, University of Washington 2007 Report No: 116. http://depts.washington.edu/uwrhrc/uploads/RHRC%20FR116%20Fordyce.pdf
16. US cardiologist workforce from 1995 to 2007: modest growth, lasting geographic maldistribution especially in rural areas. Aneja S, Ross JS, Wang Y, Matsumoto M, Rodgers GP, Bernheim SM, Rathore SS, Krumholz HM, Health Aff (Millwood) 2011 30 2301 2309 10.1377/hlthaff.2011.0255 22147857
17. Patterns of health service utilization in rural Canada. Pong RW, DesMeules M, Heng D, Lagace C, Guernsey JR, Kazanjian A, Manuel D, Pitblado JR, Bollman R, Koren I, Dressler MP, Wang F, Luo W, Chronic Dis Can 2011 31 Supp 1 1 36
18. An evaluation of access to health care services along the rural-urban continuum in Canada. Sibley LM, Weiner JP, BMC Health Serv Res 2011 11 20 10.1186/1472-6963-11-20 21281470
19. Trends in community pharmacy counts and closures before and after the implementation of Medicare part D. Klepser DG, Xu L, Ullrich F, Mueller KJ, J Rural Health 2011 27 168 175 10.1111/j.1748-0361.2010.00342.x 21457309
20. Rural residence and prescription medication use by community-dwelling older adults: a review of the literature. Grymonpre RE, Hawranik PG, J Rural Health 2008 24 203 209 10.1111/j.1748-0361.2008.00159.x 18397457
21. Heart disease and stroke statistics-2012 update: a report from the American heart association. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Soliman EZ, Circulation 2012 125 2 e220 22179539
22. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Moher D, Liberati A, Tetzlaff J, Altman DG, PLoS Med 2009 6 1000097 10.1371/journal.pmed.1000097 19621072
23. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, J Clin Epidemiol 2008 61 344 349 10.1016/j.jclinepi.2007.11.008 18313558 (Pubitemid 351289042)
24. How to obtain the confidence interval from a P value. Altman DG, Bland JM, BMJ 2011 343 2090 10.1136/bmj.d2090 21824904
25. Review Manager (RevMan). [Computer program]. Version 5.1, Review Manager (RevMan). [Computer program]. Version 5.1 Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration 2011
26. Multiple outcomes or time-points within a study. Borgenstein M, Hedges LV, Higgins JPT, Rothstein HR, Introduction to Meta-Analysis Chichester, UK: John Wiley & Sons 2009 225 238
27. Quality of care and in-hospital outcomes in patients with coronary heart disease in rural and urban hospitals (from get with the guidelines-coronary artery disease program). Ambardekar AV, Fonarow GC, Dai D, Peterson ED, Hernandez AF, Cannon CP, Krantz MJ, Am J Cardiol 2010 105 139 143 10.1016/j.amjcard.2009.09.003 20102907
28. A comparison of diabetes care in rural and urban medical clinics in Alabama. Andrus MR, Kelley KW, Murphey LM, Herndon KC, J Community Health 2004 29 29 44 14768933 (Pubitemid 39023429)
29. Adherence to vascular protection drugs in diabetic patients in Quebec: a population-based analysis. Asghari S, Courteau J, Drouin C, Gregoire JP, Carpentier AC, Paquet M, Vanasse A, Diab Vasc Dis Res 2010 7 167 171 10.1177/1479164109360593 20382781
30. Quality of care for myocardial infarction in rural and urban hospitals. Baldwin LM, Chan L, Andrilla CH, Huff ED, Hart LG, J Rural Health 2010 26 51 57 10.1111/j.1748-0361.2009.00265.x 20105268
31. Quality of care for acute myocardial infarction in rural and urban US hospitals. Baldwin LM, MacLehose RF, Hart LG, Beaver SK, Every N, Chan L, J Rural Health 2004 20 99 108 10.1111/j.1748-0361.2004.tb00015.x 15085622 (Pubitemid 38380989)
32. Hospital-level performance improvement: beta-blocker use after acute myocardial infarction. Bradley EH, Herrin J, Mattera JA, Holmboe ES, Wang Y, Frederick P, Roumanis SA, Radford MJ, Krumholz HM, Med Care 2004 42 591 599 10.1097/01.mlr.0000128006.27364.a9 15167327
33. Quality improvement efforts and hospital performance: rates of beta-blocker prescription after acute myocardial infarction. Bradley EH, Herrin J, Mattera JA, Holmboe ES, Wang Y, Frederick P, Roumanis SA, Radford MJ, Krumholz HM, Med Care 2005 43 282 292 10.1097/00005650-200503000-00011 15725985 (Pubitemid 40353911)
34. A cross-sectional study of secondary cardiac care in general practice: impact of personal and practice characteristics. Byrne M, Murphy AW, Walsh JC, Shryane E, McGroarty M, Kelleher CC, Fam Pract 2006 23 295 302 10.1093/fampra/cml003 16585129
35. Rural and urban differentials in primary care management of chronic heart failure: new data from the CASE study. Clark RA, Eckert KA, Stewart S, Phillips SM, Yallop JJ, Tonkin AM, Krum H, Med J Aust 2007 186 441 445 17484704 (Pubitemid 46806819)
36. Disparities in cardiovascular disease risk and treatment: demographic comparison. Colleran KM, Richards A, Shafer K, J Investig Med 2007 55 415 422 10.2310/6650.2007.00028 18163967 (Pubitemid 351299632)
37. Socioeconomical status of life and regularity of intake of medicines among hypertensive patients. Czarnecka D, Pawelec M, Kopacz E, Kloch M, Przegl Lek 2006 63 633 636 17441372
38. Factors associated with arterial hypertension in pharmacy users in Portugal. de Oliveira-Martins S, Oliveira T, Gomes JJF, Caramona M, Cabrita J, Rev Saude Publica 2011 45 136 144 10.1590/S0034-89102010005000056 21152705
39. Postdischarge medication use of elderly cardiac patients from urban and rural locations. Dellasega C, Orwig D, Ahern F, Lenz E, J Gerontol A Biol Sci Med Sci 1999 54 514 M520 10.1093/gerona/54.10.M514 10568534
40. Evolution of statin prescribing 1994-2001: a case of agism but not of sexism? DeWilde S, Carey IM, Bremner SA, Richards N, Hilton SR, Cook DG, Heart 2003 89 417 421 10.1136/heart.89.4.417 12639870 (Pubitemid 36379415)
41. Trends in the prevalence of diagnosed atrial fibrillation, its treatment with anticoagulation and predictors of such treatment in UK primary care. DeWilde S, Carey IM, Emmas C, Richards N, Cook DG, Heart 2006 92 1064 1070 10.1136/hrt.2005.069492 16387813 (Pubitemid 44131331)
42. Use of guideline-recommended therapies for heart failure in the medicare population. DiMartino LD, Shea AM, Hernandez AF, Curtis LH, Clin Cardiol 2010 33 400 405 10.1002/clc.20760 20641116
43. The effect of minority status and rural residence on actions to control high blood pressure in the U.S. Ellis C, Grubaugh AL, Egede LE, Public Health Rep 2010 125 801 809 21121225
44. Underutilization of antithrombotic therapy in elderly rural patients with atrial fibrillation. Flaker GC, McGowan DJ, Boechler M, Fortune G, Gage B, Am Heart J 1999 137 307 312 10.1053/hj.1999.v137.91403 9924165 (Pubitemid 29070143)
45. Trends in the use of lipid-lowering medications at discharge in patients with acute myocardial infarction: 1998 to 2006. Fonarow GC, French WJ, Frederick PD, Am Heart J 2009 157 185 194 10.1016/j.ahj.2008.09.001 19081417
46. Antihypertensive drug persistence and compliance among newly treated elderly hypertensives in Ontario. Friedman O, McAlister FA, Yun L, Campbell NR, Tu K, Am J Med 2010 123 173 181 10.1016/j.amjmed.2009.08.008 20103027
47. Physician and patient influences on provider performance: beta-blockers in postmyocardial infarction management in the MI-Plus study. Funkhouser E, Houston TK, Levine DA, Richman J, Allison JJ, Kiefe CI, Circ Cardiovasc Qual Outcomes 2011 4 99 106 10.1161/CIRCOUTCOMES.110.942318 21139090
48. Adverse outcomes and predictors of underuse of antithrombotic therapy in medicare beneficiaries with chronic atrial fibrillation. Gage BF, Boechler M, Doggette AL, Fortune G, Flaker GC, Rich MW, Radford MJ, Stroke 2000 31 822 827 10.1161/01.STR.31.4.822 10753982 (Pubitemid 30198422)
49. United States rural hospital quality in the hospital compare database-accounting for hospital characteristics. Goldman LE, Dudley RA, Health Policy 2008 87 112 127 10.1016/j.healthpol.2008.02.002 18374447
50. Changing patterns of antihypertensive drug use in a German population between 1984 and 1987. Results of a population based cohort study in the federal republic of Germany. Hense HW, Tennis P, Eur J Clin Pharmacol 1990 39 1 7 10.1007/BF02657047 2276383 (Pubitemid 20216501)
51. Comparison of HTN management in patients with diabetes between rural and urban primary care clinics in Northeastern Colorado-a report from SNOCAP. Hicks PC, Bublitz Emsermann C, Westfall JM, Parnes B, Rural Remote Health 2010 10 1 11
52. The role of different types of health insurance on access and utilization of antihypertensive drugs: an empirical study in a US hypertensive population. Huttin C, Dis Manag Health Outcome 2002 10 419 430 10.2165/00115677-200210070- 00003 (Pubitemid 34876250)
53. Lipid-lowering therapy with statins in high-risk elderly patients: the treatment-risk paradox. Ko DT, Mamdani M, Alter DA, JAMA 2004 291 1864 1870 10.1001/jama.291.15.1864 15100205 (Pubitemid 38509499)
54. A comparison of quality of care indicators in urban acute care hospitals and rural critical access hospitals in the United States. Lutfiyya MN, Bhat DK, Gandhi SR, Nguyen C, Weidenbacher-Hoper VL, Lipsky MS, Int J Qual Health Care 2007 19 141 149 10.1093/intqhc/mzm010 17442745 (Pubitemid 47090638)
55. Screening, treatment, and control of hypertension in US private physician offices, 2003-2004. Ma J, Stafford RS, Hypertension 2008 51 1275 1281 10.1161/HYPERTENSIONAHA.107.107086 18347229 (Pubitemid 351555937)
56. Beta-blocker initiation and adherence after hospitalization for acute myocardial infarction. Maio V, Marino M, Robeson M, Gagne JJ, Eur J Cardiovasc Prev Rehabil 2011 18 438 445 10.1177/1741826710389401 21450641
57. Undertreatment of hyperlipidemia in the secondary prevention of coronary artery disease. Majumdar SR, Gurwitz JH, Soumerai SB, J Gen Intern Med 1999 14 711 717 10.1046/j.1525-1497.1999.02229.x 10632815 (Pubitemid 30010838)
58. Influence of physician specialty on adoption and relinquishment of calcium channel blockers and other treatments for myocardial infarction. Majumdar SR, Inui TS, Gurwitz JH, Gillman MW, McLaughlin TJ, Soumerai SB, J Gen Intern Med 2001 16 351 359 10.1046/j.1525-1497.2001.016006351.x 11422631 (Pubitemid 34205652)
59. Thromboembolism prophylaxis in chronic atrial fibrillation: practice patterns in community and tertiary-care hospitals. Munschauer FE, Priore RL, Hens M, Castilone A, Stroke 1997 28 72 76 10.1161/01.STR.28.1.72 8996492 (Pubitemid 27039468)
60. Aspirin for primary prevention in patients with diabetes mellitus. Nguyen KX, Marinac JS, Sun C, Fam Med 2005 37 112 117 15690251 (Pubitemid 40204467)
61. Statins for secondary cardiovascular disease prevention for older primary care patients. Niska R, Han B, J Natl Med Assoc 2009 101 705 710 19634592
62. Anticoagulation for patients with atrial fibrillation in ambulatory care settings. Niska R, Han B, J Am Board Fam Med 2009 22 299 306 10.3122/jabfm.2009.03.080218 19429736
63. Geographic variation in stroke risk in the United States-region, urbanization, and hypertension in the third national health and nutrition examination survey. Obisesan TO, Vargas CM, Gillum RF, Stroke 2000 31 19 25 10.1161/01.STR.31.1.19 10625710 (Pubitemid 30035747)
64. Prevalence, awareness, treatment and control of hypertension in Galicia (Spain) and association with related diseases. Perez-Fernandez R, Marino AF, Cadarso-Suarez C, Botana MA, Tome MA, Solache I, Rego-Iraeta A, Mato AJ, J Hum Hypertens 2007 21 366 373 17301825 (Pubitemid 46637943)
65. Patterns of antihypertensive drug utilization in primary care. Pittrow D, Kirch W, Bramlage P, Lehnert H, Hofler M, Unger T, Sharma AM, Wittchen HU, Eur J Clin Pharmacol 2004 60 135 142 10.1007/s00228-004-0731-6 15042351 (Pubitemid 38626444)
66. The impact of private and public health insurance on medication use for adults with chronic diseases. Rice T, Lavarreda SA, Ponce NA, Brown ER, Med Care Res Rev 2005 62 231 249 10.1177/1077558704273806 15750178 (Pubitemid 40397255)
67. Trends in anticoagulation for atrial fibrillation in the U.S.: an analysis of the national ambulatory medical care survey database. Rowan SB, Bailey DN, Bublitz CE, Anderson RJ, J Am Coll Cardiol 2007 49 1561 1565 10.1016/j.jacc.2006.11.045 17418296 (Pubitemid 46517958)
68. Urban-rural differences in the quality of care for medicare patients with acute myocardial infarction. Sheikh K, Bullock C, Arch Intern Med 2001 161 737 743 10.1001/archinte.161.5.737 11231708 (Pubitemid 32200229)
69. Rural/urban variations in diabetes self-care and quality of care in a national sample of US adults with diabetes. Strom JL, Lynch CP, Egede LE, Diabetes Educ 2011 37 254 262 10.1177/0145721710394875 21289298
70. Determinants of the adherence to therapeutic plan in elderly Spaniards, over 60 years of age. Tuesca-Molina R, Guallar-Castillon P, Banegas-Banegas JR, Graciani-Perez Regadera A, Gac Sanit 2006 20 220 227 10.1157/13088853 16756860 (Pubitemid 44110765)
71. Cardiovascular risk management and its impact in Australian general practice patients with type 2 diabetes in urban and rural areas. Wan Q, Harris MF, Davies GP, Jayasinghe UW, Flack J, Georgiou A, Burns JR, Penn DL, Int J Clin Pract 2008 62 53 58 17927763 (Pubitemid 350294013)
72. Case volume and hospital compliance with evidence-based processes of care. Williams SC, Koss RG, Morton DJ, Schmaltz SP, Loeb JM, Int J Qual Health Care 2008 20 79 87 18174222 (Pubitemid 351436963)
73. Rurality and event-free survival in patients with heart failure. Wu JR, Moser DK, Rayens MK, De Jong MJ, Chung ML, Riegel B, Lennie TA, Heart Lung 2010 39 512 520 10.1016/j.hrtlng.2009.11.002 20561853
74. Adherence to antihypertensive treatment: a critical factor for blood pressure control. Yiannakopoulou EC, Papadopulos JS, Cokkinos DV, Mountokalakis TD, Eur J Cardiovasc Prev Rehabil 2005 12 243 249 15942423 (Pubitemid 40910852)
75. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey. Yusuf S, Islam S, Chow CK, Rangarajan S, Dagenais G, Diaz R, Gupta R, Kelishadi R, Iqbal R, Avezum A, Kruger A, Kutty R, Lanas F, Lisheng L, Wei L, Lopez-Jaramillo P, Oguz A, Rahman O, Swidan H, Yusoff K, Zatonski W, Rosengren A, Teo KK, Lancet 2011 378 1231 1243 10.1016/S0140-6736(11)61215-4 21872920
76. Medication compliance and persistence: terminology and definitions. Cramer JA, Roy A, Burrell A, Fairchild CJ, Fuldeore MJ, Ollendorf DA, Wong PK, Value Health 2008 11 44 47 10.1111/j.1524-4733.2007.00213.x 18237359 (Pubitemid 351160875)
77. Low socioeconomic status and absence of supplemental health insurance as barriers to diabetes care access and utilization. Kwan J, Razzaq A, Leiter LA, Lillie D, Hux JE, Can J Diabetes 2008 32 174 181 10.1016/S1499-2671(08)23007-8
78. A meta-analysis of the association between adherence to drug therapy and mortality. Simpson SH, Eurich DT, Majumdar SR, Padwal RS, Tsuyuki RT, Varney J, Johnson JA, BMJ 2006 333 15 10.1136/bmj.38875.675486.55 16790458